Oral Oncology
Volume 46, Issue 1 , Pages 4-8 , January 2010

Development of a gene transfer-based treatment for radiation-induced salivary hypofunction

  • Bruce J. Baum

      Affiliations

    • Molecular Physiology and Therapeutics Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD, USA
    • Corresponding Author InformationCorresponding author. Address: Bldg. 10, Room 1N113, MSC-1190, MPTB/NIDCR/NIH, 10 Center Drive, Bethesda, MD 20892-1190, USA. Tel.: +1 301 496 1363; fax: +1 301 402 1228.
    • ,
  • Changyu Zheng

      Affiliations

    • Molecular Physiology and Therapeutics Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD, USA
    • ,
  • Ilias Alevizos

      Affiliations

    • Molecular Physiology and Therapeutics Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD, USA
    • ,
  • Ana P. Cotrim

      Affiliations

    • Molecular Physiology and Therapeutics Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD, USA
    • ,
  • Shuying Liu

      Affiliations

    • Molecular Physiology and Therapeutics Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD, USA
    • ,
  • Linda McCullagh

      Affiliations

    • Molecular Physiology and Therapeutics Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD, USA
    • ,
  • Corinne M. Goldsmith

      Affiliations

    • Molecular Physiology and Therapeutics Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD, USA
    • ,
  • Nancy McDermott

      Affiliations

    • Clinical Research Core, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD, USA
    • ,
  • John A. Chiorini

      Affiliations

    • Molecular Physiology and Therapeutics Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD, USA
    • ,
  • Nikolay P. Nikolov

      Affiliations

    • Molecular Physiology and Therapeutics Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD, USA
    • ,
  • Gabor G. Illei

      Affiliations

    • Molecular Physiology and Therapeutics Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD, USA

Received 5 August 2009 ,Revised 16 September 2009 ,Accepted 17 September 2009.

References 

  1. Jamal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics 2009. CA Cancer J Clin. 2009;59:225–249
  2. Vissink A, Jansma J, Spijkervet FKL, Burlage FR, Coppes RP. Oral sequelae of head and neck radiotherapy. Crit Rev Oral Biol Med. 2003;14:199–212
  3. Vissink A, Burlage FR, Spijkervet FKL, Jansma J, Coppes RP. Prevention and treatment of the consequences of head and neck radiotherapy. Crit Rev Oral Biol Med. 2003;14:213–225
  4. Langendijk JA, Doornaert P, Verdonck-de Leeuw IM, Leemans CR, Aaronson NK, Slotman BJ. Impact of late treatment-related toxicity on quality of life among patients with head and neck cancer treated with radiotherapy. J Clin Oncol. 2008;26:3770–3776
  5. Ho KF, Farnell DJJ, Routledge JA, Burns MP, Sykes AJ, Slevin NJ, et al. Developing a CTCAEs patient questionnaire for late toxicity after head and neck radiotherapy. Eur J Cancer. 2009;45:1992–1998
  6. Teguh DN, Levendag PC, Noever I, Voet P, van der Est H, van Roou P, et al. Early hyperbaric oxygen therapy for reducing radiotherapy side effects: early results of a randomized trial in oropharyngeal and nasopharyngeal cancer. Int J Radiat Oncol Biol Phys. 2009;
  7. Brizel DM, Overgaard J. Does amifostine have a role in chemoradiation treatment?. Lancet Oncol. 2003;4:378–381
  8. Jha N, Seikaly H, Harris J, Williamd D, Sultanem K, Hier M, et al. Phase III randomized study: oral pilocarpine versus submandibular salivary gland transfer protocol for the management of radiation-induced xerostomia. Head Neck. 2009;31:234–243
  9. Chen W-C, Hwang T-Z, Wang W-H, Lu C-H, Chen C-C, Chen C-M, et al. Comparison between conventional and intensity-modulated post-operative radiotherapy for stage III and IV oral cavity cancer in terms of treatment results and toxicity. Oral Oncol. 2009;45:505–510
  10. Vergeer MR, Doornaert P, Reitvelt DHF, Leemans CR, Slotman BJ, Langendijk JA. Intensity-modulated radiotherapy reduces radiation-induced morbidity and improves health-related quality of life: results of a non-randomized prospective study using a standardized follow-up program. Int J Radiat Oncol Biol Phys. 2009;74:1–8
  11. Lee N, Harris J, Garden AS, Straube W, Glisson B, Xia P, et al. Intensity-modulated radiation therapy with or without chemotherapy for nasopharyngeal carcinoma: Radiation Therapy Oncology Group phase III trial 0225. J Clin Oncol. 2009;
  12. Cox JD, Steitz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for research and treatment of cancer. Int J Radiat Oncol Biol Phys. 1995;31:1341–1346
  13. Baum BJ, Zheng C, Cotrim AP, McCullagh L, Goldsmith CM, Brahim JS, et al. Aquaporin-1 gene transfer to correct radiation-induced salivary hypofunction. In:  Beitz E editors. Aquaporins. Handbook of experimental pharmacology. vol. 190:Berlin, Heidelberg: Springer; 2009;p. 403–418
  14. Preston GM, Agre P. Isolation of the cDNA for erythrocyte integral membrane protein of 28kilodaltons: member of an ancient channel family. Proc Natl Acad Sci USA. 1991;88:11110–11114
  15. Delporte C, O’Connell BC, He X, Lancaster HE, O’Connell AC, Agre P, et al. Increased fluid secretion after adenoviral-mediated transfer of the aquaporin-1 cDNA to irradiated rat salivary glands. Proc Natl Acad Sci USA. 1997;94:3268–3273
  16. Baum BJ. Principles of saliva secretion. Ann NY Acad Sci. 1993;694:17–23
  17. Vitolo JM, Baum BJ. The use of gene transfer for the protection and repair of salivary glands. Oral Dis. 2002;8:183–191
  18. Cherry CP, Glucksman A. Injury and repair following irradiation of salivary glands in male rats. Brit J Radiol. 1959;32:596–608
  19. Abok K, Brunck U, Jung B, Ericsson J. Morphologic and histochemical studies of the differing radiosensitivity of ductular and acinar cells of the rat submandibular gland. Virchows Arch B. 1984;45:443–460
  20. Casals M, Haskins M. Large animal models and gene therapy. Eur J Hum Genet. 2006;14:266–272
  21. O’Connell AC, Baccaglini L, Fox PC, O’Connell BC, Kenshalo D, Oweisy H, et al. Safety and efficacy of adenovirus-mediated transfer of the human aquaporin-1 cDNA to irradiated parotid glands of non-human primates. Cancer Gene Ther. 1999;6:505–513
  22. Li J, Shan Z, Ou G, Liu X, Zhang C, Baum BJ, et al. Structural and functional characteristics of irradiation damage to parotid glands in the miniature pig. Int J Radiat Oncol Biol Phys. 2005;62:1510–1516
  23. Shan Z, Li J, Zheng C, Liu X, Fan Z, Zhang C, et al. Increased fluid secretion after adenoviral-mediated transfer of the human aquaporin-1 cDNA to irradiated miniature pig parotid glands. Mol Ther. 2005;11:444–451
  24. Zheng C, Goldsmith CM, Mineshiba F, Chiorini JA, Kerr A, Wenk ML, et al. Toxicity and biodistribution of a first-generation recombinant adenoviral vector, encoding aquaporin-1, after retroductal delivery to a single rat submandibular gland. Hum Gene Ther. 2006;17:1122–1133
  25. Fox PC, Busch KA, Baum BJ. Subjective reports of xerostomia and objective measures of gland performance. J Am Dent Assoc. 1987;115:581–584
  26. Pai S, Ghezzi EM, Ship JA. Development of a visual analogue scale questionnaire for subjective assessment of salivary dysfunction. Oral Surg. 2001;91:311–316
  27. Baum BJ, Wellner RB, Zheng C. Gene transfer to salivary glands. Int Rev Cytol. 2002;213:93–146
  28. Kagami H, Atkinson JC, Michalek SM, Handelman B, Yu S, Baum BJ, et al. Repetitive adenovirus administration to the parotid gland: role of immunological barriers and induction of oral tolerance. Hum Gene Ther. 1998;9:305–313
  29. Braddon VR, Chiorini JA, Wang S, Kotin RM, Baum BJ. Adenoassociated virus-mediated transfer of a functional water channel into salivary epithelial cells in vitro and in vivo. Hum Gene Ther. 1998;9:2777–2785
  30. Voutetakis A, Kok MR, Zheng C, Bossis I, Wang J, Cotrim AP, et al. Reengineered salivary glands are stable endogenous bioreactors for systemic gene therapeutics. Proc Natl Acad Sci USA. 2004;101:3053–3058
  31. Voutetakis A, Zheng C, Mineshiba F, Cotrim AP, Goldsmith CM, Schmidt M, et al. Adeno-associated virus serotype 2-mediated gene transfer to the parotid glands of nonhuman primates. Hum Gene Ther. 2007;18:142–150
  32. Li J, Zheng C, Zhang X, Liu X, Zhang C, Goldsmith CM, et al. Developing a convenient large animal model for gene transfer to salivary glands in vivo. J Gene Med. 2004;6:55–63
  33. Harvey BG, Maroni J, O’Donoghue KA, Chu KW, Muscat JC, Pippo AL, et al. Safety of local delivery of low- and intermediate-dose adenovirus gene transfer vectors to individuals with a spectrum of morbid conditions. Hum Gene Ther. 2002;13:15–63
  34. Crystal RG, Harvey BG, Wisnivesky JP, O’Donoghue KA, Chu KW, Maroni J, et al. Analysis of risk factors for local delivery of low- and intermediate-dose adenovirus gene transfer vectors to individuals with a spectrum of comorbid conditions. Hum Gene Ther. 2002;13:65–100
  35. Raper SE, Chirmule N, Lee FS, Wivel NA, Bagg A, Gao GP, et al. Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer. Mol Genet Metab. 2003;80:148–158
  36. Baum BJ, Voutetakis A, Wang J. Salivary glands: novel target sites for gene therapeutics. Trends Mol Med. 2004;10:585–590
  37. Baum BJ, Zheng C, Cotrim AP, Goldsmith CM, Atkinson JC, Brahim JS, et al. Transfer of the AQP1 cDNA for the correction of radiation-induced salivary hypofunction. Biochim Biophys Acta. 2006;1758:1071–1077
  38. Delporte CD, Hoque ATM, Kulakusky JA, Braddon VR, Goldsmith CM, Wellner RB, et al. Relationship between adenovirus-mediated aquaporin-1 expression and fluid movement across epithelial cells. Biochem Biophys Res Commun. 1998;246:584–588

PII: S1368-8375(09)00916-6

doi: 10.1016/j.oraloncology.2009.09.004

Oral Oncology
Volume 46, Issue 1 , Pages 4-8 , January 2010

Article Tools

* Image Usage & Resolution